Fisher Expanding In-House Manufacturing Capability Through Cole-Parmer
This article was originally published in The Gray Sheet
Executive Summary
Fisher Scientific International will broaden its offerings of instrumentation and equipment used in life-science research and increase its in-house manufacturing capabilities through acquisition of privately held Cole-Parmer Instrument Company.
You may also be interested in...
Fisher Casts For Proteomics Consumables; Perbio Deal Offers Device Angle
Fisher Scientific will explore the viability of Perbio Science AB's medical device unit within a planned merger of the two companies, announced June 26
Fisher Casts For Proteomics Consumables; Perbio Deal Offers Device Angle
Fisher Scientific will explore the viability of Perbio Science AB's medical device unit within a planned merger of the two companies, announced June 26
Fisher Scientific International
Secondary offering of 12 mil. shares at $24 each, including 11 mil. shares offered by the firm and 1 mil. shares offered by selling shareholders, is announced May 3. Proceeds will be used for general corporate purposes, "including potential acquisitions," Fisher says. The Hampton, New Hampshire firm has granted an over-allotment option to purchase an additional 1.8 mil. shares to underwriters Goldman Sachs, Credit Suisse First Boston, JP Morgan, Merrill Lynch, and Morgan Stanley. Fisher's proposal to merge with medical products distributor PSS World Medical was terminated in September 2000 (1"The Gray Sheet" Sept. 11, 2000, p. 24). At the time, the firm said it would continue to seek other acquisitions